Percy AK, Neul JL, Benke TA, Berry-Kravis EM, Glaze DG, Marsh ED, Barrett AM, An D, Bishop KM, Youakim JM. Trofinetide for the treatment of Rett syndrome: long-term safety and efficacy results of the 32-month, open-label LILAC-2 study. Med. 2024 Oct 11;5(10):1275-1281. doi: 10.1016/j.medj.2024.06.007
Hoogeveen EK, Rothman KJ. Hyperhomocysteinemia increases the risk of death in type 2 diabetes. Cardiovasc Rev Rep. 2001;22:207-12.